Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer
- 30 September 1998
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 116 (3) , 412-416
- https://doi.org/10.1016/s0022-5223(98)70007-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Do Molecular Markers Predict Survival in Non–Small-Cell Lung Cancer?American Journal of Respiratory and Critical Care Medicine, 1998
- Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancerBritish Journal of Cancer, 1996
- Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancerThe Annals of Thoracic Surgery, 1994
- Prognostic value of pretreatment CEA, SCC-Ag and CA 19–9 levels in sera of patients with non-small cell lung cancerEuropean Journal Of Cancer Prevention, 1992
- Carcinoembryonic antigen and prognosis after radical surgery for lung cancer: Immunocytochemical localization and serum levelsBritish Journal of Cancer, 1981
- Carcinoembryonic antigen: its role as a marker in the management of cancer. Summary of an NIH consensus statement.BMJ, 1981
- Preoperative carcinoembryonic antigen and survival after resection of lung cancerRespiratory Medicine, 1980
- Measurement of carcinoembryonic antigen in patients with bronchogenic carcinomaCancer, 1978
- Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinomaCancer, 1978
- Carcinoembryonic antigen in 228 patients with carcinoma of the lungCancer, 1975